Xencor, Inc. - Common Stock (NQ:XNCR)

25.34 +0.50 (+2.03%)

Delayed Quote Updated: 10:03 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Xencor, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Earnings Scheduled For November 7, 2022 ↗

November 07, 2022

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.

Via Benzinga

Xencor Earnings Preview ↗

November 04, 2022

Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report an...

Via Benzinga

Xencor to Present New Clinical Data from the Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin’s Lymphoma at the American Society of Hematology Annual Meeting

November 03, 2022

From Xencor, Inc.

Via Business Wire

Xencor's Return On Capital Employed Overview ↗

August 11, 2022

Via Benzinga

Xencor to Host Third Quarter 2022 Financial Results Webcast and Conference Call on November 7, 2022

October 31, 2022

From Xencor, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗

October 13, 2022

Upgrades

Via Benzinga

Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting

October 05, 2022

From Xencor, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 ↗

September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...

Via Benzinga

Xencor Appoints Nancy Valente, M.D., to Board of Directors

September 09, 2022

From Xencor, Inc.

Via Business Wire

Xencor Reports Second Quarter 2022 Financial Results

August 03, 2022

From Xencor, Inc.

Via Business Wire

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022

July 27, 2022

From Xencor, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

June 13, 2022

During Monday's trading, 1214 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 10, 2022

On Friday, 422 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors

May 26, 2022

From Xencor, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

7 High-Risk, High-Reward Small-Cap Stocks to Buy Now ↗

May 13, 2022

Many small-cap stocks in the S&P 600 Small Cap Index aren't big names, but they have the change of bringing big rewards.

Via InvestorPlace

Xencor Reports First Quarter 2022 Financial Results

May 05, 2022

From Xencor, Inc.

Via Business Wire

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗

May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For May 5, 2022 ↗

May 05, 2022

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

Via Benzinga

Xencor's Earnings Outlook ↗

May 04, 2022

Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

Xencor to Host First Quarter 2022 Financial Results Webcast and Conference Call on May 5, 2022

April 28, 2022

From Xencor, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

April 18, 2022

On Monday, 466 companies hit new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022

April 08, 2022

From Xencor, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

March 15, 2022

During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 08, 2022

Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 07, 2022

On Monday, 524 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Taiwan...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.